Sunday, November 17, 2024
- 10:30AM-12:30PM
-
Abstract Number: 1044
Analysis of Rheumatic Patients’ Self – Reported Symptoms in Free Written Text Using Natural Language Processing
Health Services Research – ACR/ARP Poster II- 10:30AM-12:30PM
-
Abstract Number: 1272
Angiopoietin-2 and Soluble Tumor Necrosis Factor Receptor Type II Are Elevated in Treatment Naïve JDM Plasma and Associate with Increased Muscle Disease Activity and Decreased Nailfold Capillary Density
Pediatric Rheumatology – Clinical Poster II- 10:30AM-12:30PM
-
Abstract Number: 1548
Anifrolumab in Systemic Lupus Erythematosus. Spanish National Registry in a Real-world Setting
SLE – Treatment Poster II- 10:30AM-12:30PM
-
Abstract Number: 1056
Annual Cost of Biologic Disease-modifying Antirheumatic Drugs for Rheumatoid Arthritis
Health Services Research – ACR/ARP Poster II- 10:30AM-12:30PM
-
Abstract Number: 1266
Anti-Mitochondrial Antibodies Associate with Disease Activity and IFNα Expression in Childhood-onset Systemic Lupus Erythematosus
Pediatric Rheumatology – Clinical Poster II- 10:30AM-12:30PM
-
Abstract Number: 1610
Anti-neutrophil Cytoplasmic Antibodies Associated Interstitial Pneumonia: A New Clinical Entity?
Vasculitis – ANCA-Associated Poster II- 10:30AM-12:30PM
-
Abstract Number: 1159
Anti-synthetase Syndrome (ASSD) Related Interstitial Lung Disease (ILD) in Comparison to Non-ASSD Related ILDs: Analysis from the “Classification Criteria for Anti-synthetase Syndrome (CLASS)” Project Database
Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster II- 10:30AM-12:30PM
-
Abstract Number: 1575
Anti-U1RNP Antibodies Are Associated with a Distinct Clinical Phenotype and a Worse Survival in Patients with Systemic Sclerosis
Systemic Sclerosis & Related Disorders – Clinical Poster II- 10:30AM-12:30PM
-
Abstract Number: 0918
Anti-VISTA Antibody Suppresses Neutrophil-mediated Inflammation
Innate Immunity Poster- 10:30AM-12:30PM
-
Abstract Number: 1603
Antineutrophil Cytoplasmic Autoantibody Levels in Patients in the Avacopan Phase 3 Trial
Vasculitis – ANCA-Associated Poster II- 10:30AM-12:30PM
-
Abstract Number: 0988
Antinuclear Antibody Positivity and Its Diagnostic Implications for Rheumatic Diseases in Dermatology Patients: A Comprehensive Single Center Analysis
Epidemiology & Public Health Poster II- 10:30AM-12:30PM
-
Abstract Number: 1419
Antiphospholipid Antibodies and Hypercoagulable Events in Patients with Sjogren’s Syndrome
Sjögren's Syndrome – Basic & Clinical Science Poster I- 10:30AM-12:30PM
-
Abstract Number: 1267
Antiphospholipid Antibody-related Clinical Manifestations Presenting During Childhood versus Adulthood: Descriptive Results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)